Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ginsberg

Showing results (231-240 of 369) with videos related to

Pageof 37
Sort By:
Lancet (London, England)|August 4, 1990
Preconception genetic diagnosis of cystic fibrosisC M Strom, Y Verlinsky, S Milayeva, et al.
Cell Metabolism|February 11, 2014
The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescueGwang-Woong Go, Roshni Srivastava, Antonio Hernandez-Ono, et al.
The American Journal of Clinical Nutrition|December 3, 1999
HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjectsL Berglund, E H Oliver, N Fontanez, et al.
Biochimica Et Biophysica Acta|June 14, 1985
Immunoaffinity isolation of apolipoprotein E-containing lipoproteinsJ C Gibson, A Rubinstein, N Ngai, et al.
Journal of the American Dietetic Association|June 9, 2005
Cholesterol-lowering benefits of oat-containing cereal in Hispanic americansWahida Karmally, Maria G Montez, Walter Palmas, et al.
Diabetes Care|August 28, 2023
The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD ParticipantsLeah E Cahill, Rachel A Warren, Allie S Carew, et al.
Arteriosclerosis (Dallas, Tex.)|July 1, 1987
Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemiaJ C Gibson, R B Goldberg, A Rubinstein, et al.
Cardiovascular Drugs and Therapy|September 14, 2016
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or HigherHenry N Ginsberg, Daniel J Rader, Frederick J Raal, et al.
The Journal of Clinical Investigation|November 1, 1986
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivoH N Ginsberg, N A Le, I J Goldberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1990
Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistributionJ M Rosen, S P Butler, G E Meinken, et al.
Pageof 37

Showing results (231-240 of 369) with videos related to

Sort By:
Pageof 37
Lancet (London, England)|August 4, 1990
Preconception genetic diagnosis of cystic fibrosisC M Strom, Y Verlinsky, S Milayeva, et al.
Cell Metabolism|February 11, 2014
The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescueGwang-Woong Go, Roshni Srivastava, Antonio Hernandez-Ono, et al.
The American Journal of Clinical Nutrition|December 3, 1999
HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjectsL Berglund, E H Oliver, N Fontanez, et al.
Biochimica Et Biophysica Acta|June 14, 1985
Immunoaffinity isolation of apolipoprotein E-containing lipoproteinsJ C Gibson, A Rubinstein, N Ngai, et al.
Journal of the American Dietetic Association|June 9, 2005
Cholesterol-lowering benefits of oat-containing cereal in Hispanic americansWahida Karmally, Maria G Montez, Walter Palmas, et al.
Diabetes Care|August 28, 2023
The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD ParticipantsLeah E Cahill, Rachel A Warren, Allie S Carew, et al.
Arteriosclerosis (Dallas, Tex.)|July 1, 1987
Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemiaJ C Gibson, R B Goldberg, A Rubinstein, et al.
Cardiovascular Drugs and Therapy|September 14, 2016
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or HigherHenry N Ginsberg, Daniel J Rader, Frederick J Raal, et al.
The Journal of Clinical Investigation|November 1, 1986
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivoH N Ginsberg, N A Le, I J Goldberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1990
Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistributionJ M Rosen, S P Butler, G E Meinken, et al.
Pageof 37